In 2012, the University of Michigan (U-M) partnered with Technion Institute of Technology and the Weizmann Institute of Science to support meritorious research, foster innovation and spur collaboration in the areas of biomedical sciences.
The partnership awards funding to support collaborative research projects led by scientists from the three institutions. Projects are awarded based on their potential to lead to scientific advances in understanding pathways of disease, novel diagnostics or therapeutics, as well as to peer-reviewed publication, and potentially other extramural support.
Research projects from all three institutions are presented during the annual D. Dan and Betty Kahn symposium, which this year runs September 4-8 in Israel. The focus of this year's symposium is to explore the convergence of biomedicine and bioengineering.
On behalf of the University of Michigan – Israel Partnership for Research, applications for collaborative research are being requested. The purpose of this RFA is to support meritorious research, to foster innovation, and to spur collaboration between three great academic institutions in the areas of biomedical sciences.
Awards will support a collaborative research project which requires one Principal Investigator (PI) from the University of Michigan (U-M), and one Principal Investigator (PI) from either the Technion Institute of Technology or the Weizmann Institute of Science. Awards will be given to each successful joint project between the U-M and the Technion, or between U-M and the Weizmann Institute. These UM-Israel Collaborative Research Project Grants
should lead to scientific advances in understanding pathways of disease, novel diagnostics, or therapeutics, as well as to peer-reviewed publication, and potentially other extramural support. Past recipients of UM-Israel Partnership for Research grants are eligible to re-apply, with grants evaluated on a competitive basis along with new grant applications.
The initial amount of support anticipated is $50,000 US, with an appropriate budget justification for the joint projects. Sharing of funds between sites should be directed by project need but is typically half of the award to each investigative team. Funds should be expended for the approved research within the first year of the project proposal. Plans for reciprocal institutional visits are required as part of this initiative. If awarded, $2,500 of the awarded funds to each site in Israel and Michigan should be used to offset travel expenses of the PI or a researcher from their laboratory to the reciprocal institution.
In addition to the direct research project support described above, fellowships for research trainees, such as graduate students, will also be awarded at $10,000 each. For these UM-Israel Research Training Fellowships
, potential trainees should send a current CV and one page of a proposed research plan including: Title, Hypothesis, Goal, Methodologies, Research Plan, and Preliminary Results. Agreement from a faculty preceptor at U-M, Technion, or Weizmann, should be provided. Applicants may propose travel either to the United States or to Technion or to Weizmann to further their scientific training in biomedicine under the auspices of the University of Michigan-Israel Partnership for Research.
Proposals will be evaluated by a joint committee comprised of members from the University of Michigan, the Technion, and the Weizmann faculty, with emphasis placed in review on innovation, collaboration, feasibility, track record of accomplishment, and likelihood of achieving success. Final funding amounts for each awarded application including split between each site PI will be determined after committee review. Awards include expectation to work towards collaboration publications and external support. Reports of progress in this regard will be required for recipients of this award.